Clinical Trial Update: Melanoma Treatment With White Blood Cells That Destroy MART Expressing Tumor Cells [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating MART-expressing tumor cell therapy for metastatic melanoma; the study was terminated and results were posted in 2014.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma
• Skin Cancer

Drugs mentioned

• MART-expressing tumor cell therapy

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Metastatic Melanoma, Skin Cancer | Phase 2 | Status: TERMINATED | Results posted: 2014-06-10